<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Press Coverage

Tumor-infiltrating lymphocytes plus pembrolizumab active in metastatic HNSCC

Default sub title

Author Healio | Publish Date November 19, 2020

The combination of an investigational cell therapy using tumor-infiltrating lymphocytes and pembrolizumab induced responses among a small cohort of patients with metastatic head and neck squamous cell carcinoma, study results showed.